Patent application number | Description | Published |
20140256909 | CURABLE COMPOSITIONS - A curable composition including (a) at least one divinylarene dioxide; (b) at least one polyol; and (c) at least one cure catalyst, said cure catalyst being effective in catalyzing the reaction between the divinylarene dioxide and the polyol and being active at ambient and higher temperatures, wherein the curable composition forms a compatible mixture; and cured compositions prepared from the curable composition. | 09-11-2014 |
20150218428 | POLYURETHANE BASED INSULATED GLASS SEALANT - Embodiments of the invention provide for polyurethane-based sealants. The sealants include a reaction product of a reaction system which includes at least one isocyanate, and at least one polyester polyol. The polyester polyol includes a reaction product of a polyester reaction mixture which includes one or more hydrophobic monomers, one or more organic diacids or methyl esters thereof, and one or more diols. | 08-06-2015 |
20150291862 | NON-ISOCYANATE SEALANT FOR GLASS SEALING - Elastomeric sealants for sealing glass to a substrate are prepared by applying a curable reaction mixture between glass and substrate, and curing the mixture. The curable reaction mixture contains a polyene compound, an epoxy resin, a thiol curing agent and a basic catalyst. The polyene compound has an average of at least two groups containing aliphatic carbon-carbon double bonds capable of reaction with a thiol group. At least one of said aliphatic carbon-carbon double bonds is separated from each other said aliphatic carbon-carbon double bond by an aliphatic spacer group having a weight of at least 500 atomic mass units. | 10-15-2015 |
20160002512 | Polyurethane Sealant Based on Poly(Butylene Oxide) Polyols for Glass Sealing - A polyurethane glass sealant is made by reacting a poly(1,2-butylene oxide) polymer with a chain extender and a polyisocyanate. The poly(1,2-butylene oxide) polymer may be used as a mixture with up to 50% by weight of other polyols, including castor oil. The sealant is especially useful as a secondary sealant for an insulated glass unit (IGU). | 01-07-2016 |
Patent application number | Description | Published |
20090144364 | SMART NODES FOR WEB SERVICES - A smart node is integrated with each Web service in a Web service application chain to automatically supply compatible features, missing functionality. and orchestration of the processes in the application, without coordination by an orchestration engine, in an embodiment. A smart node is a software program that systematically specifies the communications dimensions, functionality, and orchestration required for interoperability among Web services. The communications parameters, backup functionality. and process orchestration required for the Web services in a Web service application may be predetermined and programmed into smart nodes. The smart nodes are subsequently integrated with the Web services in a Web service application so that communications among the Web services occur first through the smart nodes. The smart nodes can thus supply communications parameters, any missing functionality, and dynamic process orchestration based on the current event context of the Web service application. A smart node further enables a Web service to supply different functionality in different contexts. | 06-04-2009 |
20120185423 | CASCADING DEFINITION AND SUPPORT OF EDI RULES - Electronic data interchange (EDI) documents are validated by creating an inventory of all rules, dynamically adjusting the inventory based upon entity specific rules derived from a plurality of companion guides, determining a profile containing pointers to select rules in the inventory for each companion guide and storing the profile for each companion guide in a storage. A runtime checker can then be used to check a received EDI document with a corresponding rule set, forward the EDI document if the EDI document matches its current rule set and return the EDI document if the EDI document does not match its current rule set. EDI rules may be enforced, for example, by determining entity-specific rules from corresponding companion guides, by expressing each rule in a neutral and machine readable format, by classifying the rules and/or by creating an inventory of rules and pointers to entity-specific rules. | 07-19-2012 |
Patent application number | Description | Published |
20090167429 | METHODOLOGY FOR ASSESSING DEGRADATION DUE TO RADIO FREQUENCY EXCITATION OF TRANSISTORS - One embodiment relates to an on-chip power amplifier (PA) test circuit. In one embodiment, a PA test circuit comprises a controllable oscillator (CO) configured to generate a radio frequency (RF) signal, a parallel resonant circuit tuned to the radio frequency, a pre-power amplifier (PPA) coupled to the CO and the parallel resonant circuit, the PPA configured to amplify and drive the RF signal from an output of the PPA into a load. The test circuit may further comprise a first transmission gate configured to couple the RF signal from the CO to an input of the PPA. One testing methodology for a PA test circuit comprises stressing the PPA with an RF signal, measuring a characteristic of the PPA, determining stress degradation from the characteristic measurements, and repeating the stressing and characteristic measurements until a maximum stress degradation is achieved or a maximum stress has been applied. | 07-02-2009 |
20090187869 | Budgeting Electromigration-Related Reliability Among Metal Paths In The Design Of A Circuit - Apportioning unequally contributions of different metal paths of a circuit to electromigration (EM) reliability. In an embodiment, a corresponding parameter value representing a magnitude of excess current flowing in a single direction in each metal path is determined. A desired reliability measure for electromigration (EM) is apportioned among the metal paths based on computed parameter values for the corresponding metal path. A reliability analysis for the circuit is performed based on the apportioning. In an embodiment, metal paths which predominantly carry currents with an average value less than a threshold are excluded from being considered as contributors to EM degradation. | 07-23-2009 |
20100038683 | INTEGRATED CIRCUIT MODELING, DESIGN, AND FABRICATION BASED ON DEGRADATION MECHANISMS - An integrated circuit (IC) includes at least a first complementary MOS (CMOS) circuit, the first CMOS circuit comprising one or more first n-channel MOS (NMOS) transistors and one or more first p-channel MOS (PMOS) transistors, where the first NMOS transistors and the first PMOS transistors are arranged in the first CMOS circuit to drive at least a first common node of the first CMOS circuit. An average of the effective gate channel lengths of the first NMOS transistors (first NMOS average length) is at least 2% greater than an average of the effective gate channel lengths of the first PMOS transistors (first PMOS average length). | 02-18-2010 |
20100164533 | METHOD AND APPARATUS FOR EVALUATING THE EFFECTS OF STRESS ON AN RF OSCILLATOR - Apparatus and methods are disclosed for evaluating degradation of a transistor in a cross coupled pair of an RF oscillator independently. A MOS device can be coupled between a separated center-tap inductor. By appropriately sizing the MOS device and turning the MOS device on during operation of RF oscillator, a good contact can again be made that allows the oscillator to operate at design performance. By turning the MOS device off, the supplies can be separates such that I-V characteristics of both transistors of the cross-coupled pair may be obtained. | 07-01-2010 |
20110291754 | Segmented Power Amplifier with Varying Segment Activation - Various apparatuses and methods for varying segment activation in a segmented power amplifier are disclosed herein. For example, some embodiments provide a power amplifier including an input, an output, a plurality of amplifier segments and a controller. The amplifier segments are connected in parallel between the input and the output and are adapted to be activated and inactivated. The power level at the output may be controlled by changing a number of the amplifier segments that are activated concurrently. The controller is connected to the amplifier segments and is adapted to vary which of the amplifier segments are activated to arrive at a selected number of activated amplifier segments. | 12-01-2011 |
Patent application number | Description | Published |
20110052672 | TREATMENTS OF DISEASE OR DISORDERS USING NANOPARTICLES FOR FOCUSED HYPERTHERMIA TO INCREASE THERAPY EFFICACY - Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy. Methods for treating a target area may comprise systemically introducing nanoparticles into an organism; allowing the nanoparticles to preferentially accumulate in the target area, applying an external energy where the nanoparticles are adapted to transduce at least a portion of the external energy into a heal energy so as to create a focused localized hyperthermia; and applying a subsequent additional therapy. | 03-03-2011 |
20130158336 | USE OF NANOPARTICLES IN THE PHOTODYNAMIC TREATMENT OF TUMORS AND NON-DESTRUCTIVE TESTING - A method for generating light intensity inside a tumor to aid in the treatment of diseases such as cancer is disclosed. The light is generated inside the body to perform a modified photodynamic therapy treatment (PDT) that allows treatment of body regions that are inaccessible by normal PDT procedures. In addition, the use of two spatially and temporally coincident treatment modalities, i.e. radiation and PDT, have the potential for significant biological synergy in the tumor. | 06-20-2013 |
20130197295 | TREATMENTS OF DISEASE OR DISORDERS USING NANOPARTICLES FOR FOCUSED HYPERTHERMIA TO INCREASE THERAPY EFFICACY - Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy. Methods for treating a target area may comprise systemically introducing nanoparticles into an organism; allowing the nanoparticles to preferentially accumulate in the target area, applying an external energy where the nanoparticles are adapted to transduce at least a portion of the external energy into a heat energy so as to create a focused localized hyperthermia; and applying a subsequent additional therapy. | 08-01-2013 |
20130225901 | ENHANCEMENT OF RADIATION THERAPY BY TARGETED HIGH-Z NANOPARTICLES - A method for the design, manufacturing, and use of a high-Z particle to enhance the effects of ionizing radiation. In particular, the use of a targeting molecule to enable cellular uptake by the target cells (tumor cells or endothelial cells proximate to the tumor) will enhance the dose effect. | 08-29-2013 |